2Hall M J, Reid JE, Burbidge LA, et al. BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer [ J ]. Cancer,2009,115 (10) :2222-2233.
3Meads C, Ahmed I, Riley RD. A systemat- ic review of breast cancer incidence risk prediction models with meta-analysis of their performance[J]. Breast Cancer Res Treat,2012,132(2) :365-377.
4Gall MH, Brinton LA, Byar DP et al. Pro- jecting individualized probabilities of de- veloping breast cancer for white females who are being examined annually [J]. J Natl Cancer last,1989,81 (24) :1879-1886.
5Anderson SJ, Ahnn S, Duff K. NSABP Breast Cancer Prevention Trial risk as ses- sment program, version 2 [ J]. NSABP Bio- statistical Center Technical Report, 1992.
6Roekhill B, Spiegelman D, Byrne C, et al. Validation of the Gall et almodel of breast cancer risk prediction and implications for chemoprevention[ J ]. J Natl Cancer Inst, 2001,93 ( 5 ) :358-366.
7Adams-CampbeU LL, Makambi KH, Palm- er JR, et al. Diagnostic accuracy of the Gail model in the Black Women's Health Study[J]. Breast,2007 ,13(4) :332-336.
8Chay WY, Ong WS, Tan PH, et al. Valida- tion of the Gall model for predicting indi- vidual breast cancer risk in a prospective nationwide study of 28, 104 Singapore women [ J] Breast Cancer Res, 2012,30, 14 ( 1 ) : R19.
9Poll6n M, Aseunce N, Ederra M, et al. Mammographie density and risk of breast cancer according to tumor characteristics and mode of detection : a Spanish popula- tion-based case-control study [ J ]. Breast Cancer Res,2013,29,15 ( 1 ) : R9. [ Epub ahead of print].
10Darahi H, Czene K, Zhao W, et al. Breast cancer risk prediction and individualised screening based on common genetic varia- tion and breast density measurement [ J ].Breast Cancer Res,2012,7,14( 1 ) :R25.
3Dupont WD, Pad FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypicalhyperplasia [J]. Cancer. 1993, 71 : 1258-1265.
1Sharma S , Dorwal P , Sachdev R, et al. Primary follicular lymphoma of the breast : a rare clinical entity diagnosed using tis- sue flow eytometry [ J ]. Indian journal of hematology & blood transfusion, 2015,31 (2) :300-301.
2Manna B, Saber B, Tijani EH, et al. Pri- mary malignant non-Hodgkin' s lymphoma of the breast : a study of seven eases and literature review [ J ]. World Journal of Surgical Oneology,2012,10( 1 ) :217.
3Aviv A, Tadmor T, Polliack A. Primary diffuse large B-cell lymphoma of the breast : looking at pathogenesis, clinical issues and therapeutic options [ J ]. An- nals of Oncology, 2013,24 ( 9 ) : 2236- 2244.
4Arora SK, Gupta N, Srinivasan R, et al. Non-Hodgkin "s lymphoma presenting as breast masses: A series of 10 cases diag- nosed on FNAC [ J ]. Diagnostic Cytopa- thology ,2013,41 ( 1 ) :53-59.
5Aviles A, Neri N, Nambo MJ. The Role of Genotype in 104 Cases of Diffuse Large B- Cell Lymphoma Primary of Breast[ J]. Am J Clin Oncol,2012,35(2) :126-129.
6Arora S K, Gupta N, Srinivasan R, et al. Non-Hodgkin "s lymphoma presenting as breast masses: A series of 10 cases diag- nosed on FNAC [ J ]. Diagnostic Cytopa- thology,2013,41 ( 1 ) :53-59.
7Li D, Deng J, He H, et al. Primary breast diffuse large B-eell lymphoma shows an activated B-cell-like phenotype [ J ]. An- nals of Diagnostic Pathology, 2012, 16 (5) :335-343.
8Lazzeri D, Agostini T, Bocci G, et al. ALK-l-egative aoaplastie large cell lym- phoma associated with breast implants : a new clinical entity [ J ]. Clinical Breast Cancer, 2011,11 ( 5 ) : 283-296.
9Kim B,Roth C,Chung KC, et al. Anaplas- tic Large Cell Lymphoma and Breast Im- plants :A Systematic Review[ J ]. Plastic & Reconstructive Surgery, 2011,127 ( 6 ) : 2141-2150.
10Jeanneret-Sozzi W, Taghian A, Epelbanm R, et al. Primary breast lymphoma: Patient profile, outcome and prognostic factors. A muhieentre Rare Caneer Network study [ J ]. Bmc Cancer,2008,8 (2) :86.
